Follow
Daniel Spratt
Daniel Spratt
University Hospitals Seidman Cancer Center/CWRU
Verified email at uhhospitals.org
Title
Cited by
Cited by
Year
Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology
JL Mohler, ES Antonarakis, AJ Armstrong, AV D’Amico, BJ Davis, T Dorff, ...
Journal of the National Comprehensive Cancer Network 17 (5), 479-505, 2019
7812019
Genomic hallmarks and structural variation in metastatic prostate cancer
DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ...
Cell 174 (3), 758-769. e9, 2018
3912018
International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery
BW Cox, DE Spratt, M Lovelock, MH Bilsky, E Lis, S Ryu, J Sheehan, ...
International Journal of Radiation Oncology* Biology* Physics 83 (5), e597-e605, 2012
3742012
Androgen receptor signaling regulates DNA repair in prostate cancers
WR Polkinghorn, JS Parker, MX Lee, EM Kass, DE Spratt, PJ Iaquinta, ...
Cancer discovery 3 (11), 1245-1253, 2013
3702013
A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy
ZS Zumsteg, DE Spratt, I Pei, Z Zhang, Y Yamada, M Kollmeier, ...
European urology 64 (6), 895-902, 2013
3312013
Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer
DE Spratt, X Pei, J Yamada, MA Kollmeier, B Cox, MJ Zelefsky
International Journal of Radiation Oncology* Biology* Physics 85 (3), 686-692, 2013
2732013
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer
A Bosch, Z Li, A Bergamaschi, H Ellis, E Toska, A Prat, JJ Tao, DE Spratt, ...
Science translational medicine 7 (283), 283ra51-283ra51, 2015
2642015
Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis
R Morrison, SM Schleicher, Y Sun, KJ Niermann, S Kim, DE Spratt, ...
Journal of oncology 2011, 2011
2552011
Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9 …
AU Kishan, RR Cook, JP Ciezki, AE Ross, MM Pomerantz, PL Nguyen, ...
Jama 319 (9), 896-905, 2018
2282018
Association of black race with prostate cancer–specific and other-cause mortality
RT Dess, HE Hartman, BA Mahal, PD Soni, WC Jackson, MR Cooperberg, ...
JAMA oncology 5 (7), 975-983, 2019
2062019
Racial/ethnic disparities in genomic sequencing
DE Spratt, T Chan, L Waldron, C Speers, FY Feng, OO Ogunwobi, ...
JAMA oncology 2 (8), 1070-1074, 2016
1942016
Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy
SG Zhao, SL Chang, N Erho, M Yu, J Lehrer, M Alshalalfa, C Speers, ...
JAMA oncology 3 (12), 1663-1672, 2017
1852017
Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality
DE Spratt, C Zhang, ZS Zumsteg, X Pei, Z Zhang, MJ Zelefsky
European urology 63 (4), 709-716, 2013
1772013
Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies
WC Jackson, J Silva, HE Hartman, RT Dess, AU Kishan, WH Beeler, ...
International Journal of Radiation Oncology* Biology* Physics 104 (4), 778-789, 2019
1642019
Individual patient-level meta-analysis of the performance of the decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease
DE Spratt, K Yousefi, S Deheshi, AE Ross, RB Den, EM Schaeffer, ...
Journal of Clinical Oncology 35 (18), 1991, 2017
1642017
Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer
AU Kishan, A Dang, AJ Katz, CA Mantz, SP Collins, N Aghdam, FI Chu, ...
JAMA network open 2 (2), e188006-e188006, 2019
1622019
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
SG Zhao, SL Chang, DE Spratt, N Erho, M Yu, HAD Ashab, M Alshalalfa, ...
The lancet oncology 17 (11), 1612-1620, 2016
1612016
Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors
RJ Passarella, DE Spratt, AE Van Der Ende, JG Phillips, H Wu, ...
Cancer research 70 (11), 4550-4559, 2010
1612010
An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report
DE Spratt, WH Beeler, FY de Moraes, LD Rhines, JJ Gemmete, ...
The Lancet Oncology 18 (12), e720-e730, 2017
1602017
The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy
ZS Zumsteg, DE Spratt, PB Romesser, X Pei, Z Zhang, W Polkinghorn, ...
European urology 67 (6), 1009-1016, 2015
1562015
The system can't perform the operation now. Try again later.
Articles 1–20